Going with the flow, and beyond, in myeloma

Por Barlogie, Bart, Epstein, Joshua, Shaughnessy, John D.
Publicado em 2008

Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth

Por Qiang, Ya-Wei, Shaughnessy, John D., Yaccoby, Shmuel
Publicado em 2008

Overview of biological database mapping services for interoperation between different 'omics' datasets

Por Chavan, Shweta S, Shaughnessy, John D, Edmondson, Ricky D
Publicado em 2011

High-risk myeloma: a gene expression–based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed diseas...

Por Zhan, Fenghuang, Barlogie, Bart, Mulligan, George, Shaughnessy, John D., Bryant, Barb
Publicado em 2008

Tumor Cell Gene Expression Changes Following Short-term In vivo Exposure to Single Agent Chemotherapeutics are Related to Survival in Multiple Myeloma

Por Burington, Bart, Barlogie, Bart, Zhan, Fenghuang, Crowley, John, Shaughnessy, John D.
Publicado em 2008

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo

Por Yaccoby, Shmuel, Ling, Wen, Zhan, Fenghuang, Walker, Ronald, Barlogie, Bart, Shaughnessy, John D.
Publicado em 2007

Proteasome inhibitors and bone disease

Por Qiang, Ya-Wei, Heuck, Christoph J., Shaughnessy, John D., Barlogie, Bart, Epstein, Joshua
Publicado em 2012

Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols

Por Nair, Bijay, Waheed, Sarah, Szymonifka, Jackie, Shaughnessy, John D., Crowley, John, Barlogie, Bart
Publicado em 2008

Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive Medicine

Por Matsui, Shigeyuki, Simon, Richard, Qu, Pingping, Shaughnessy, John D., Barlogie, Bart, Crowley, John
Publicado em 2012

Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines

Por Li, Xin, Pennisi, Angela, Zhan, Fenghuang, Sawyer, Jeffrey R., Shaughnessy, John D., Yaccoby, Shmuel
Publicado em 2007

The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

Por Pennisi, Angela, Ling, Wen, Li, Xin, Khan, Sharmin, Shaughnessy, John D., Barlogie, Bart, Yaccoby, Shmuel
Publicado em 2009

Bortezomib induces osteoblast differentiation via Wnt-independent activation of β-catenin/TCF signaling

Por Qiang, Ya-Wei, Hu, Bo, Chen, Yu, Zhong, Ying, Shi, Bingyin, Barlogie, Bart, Shaughnessy, John D.
Publicado em 2009

Characterization of Wnt/β-catenin signalling in osteoclasts in multiple myeloma

Por Qiang, Ya-Wei, Chen, Yu, Brown, Nathan, Hu, Bo, Epstein, Joshua, Barlogie, Bart, Shaughnessy, John D.
Publicado em 2009

Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone

Por Pennisi, Angela, Ling, Wen, Li, Xin, Khan, Sharmin, Wang, Yuping, Barlogie, Bart, Shaughnessy, John D., Yaccoby, Shmuel
Publicado em 2010

Ribosomal protein metallopanstimulin-1 impairs multiple myeloma CAG cells growth and inhibits fibroblast growth factor receptor 3

Por Dai, Yuemeng, Pierson, Spencer, Dudney, Cross, Zeng, Yuxin, MacLeod, Veronica, Shaughnessy, John D., Stack, Brendan C.
Publicado em 2011

Clinical, Immunophenotypic, and Genetic Characterization of Small Lymphocyte–Like Plasma Cell Myeloma: A Potential Mimic of Mature B-Cell Lymphoma

Por Heerema-McKenney, Amy, Waldron, James, Hughes, Steven, Zhan, Fenghuang, Sawyer, Jeffery, Barlogie, Bart, Shaughnessy, John D.
Publicado no Am J Clin Pathol (2010)

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

Por Qiang, Ya-Wei, Chen, Yu, Stephens, Owen, Brown, Nathan, Chen, Bangzheng, Epstein, Joshua, Barlogie, Bart, Shaughnessy, John D.
Publicado em 2008

Reiterative Survival Analyses of Total Therapy 2 for Multiple Myeloma Elucidate Follow-Up Time Dependency of Prognostic Variables and Treatment Arms

Por Barlogie, Bart, Anaissie, Elias, van Rhee, Frits, Shaughnessy, John D., Szymonifka, Jackie, Hoering, Antje, Petty, Nathan, Crowley, John
Publicado em 2010

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

Por Johnson, Sarah K., Heuck, Christoph J., Albino, Anthony P., Qu, Pingping, Zhang, Qing, Barlogie, Bart, Shaughnessy, John D.
Publicado no Int J Hematol (2011)

CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27(Kip1)-dependent and -independent mechanisms

Por Zhan, Fenghuang, Colla, Simona, Wu, Xiaosong, Chen, Bangzheng, Stewart, James P., Kuehl, W. Michael, Barlogie, Bart, Shaughnessy, John D.
Publicado em 2007